Jean Luc Canon

Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer

Jean‐Yves Douillard, Kelly S. Oliner, Salvatore Siena et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi et al. · Journal of Clinical Oncology · 2006 · 220 citations · Full text

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Paul Cottu, Véronique D’Hondt, Sylvain Dureau et al. · Annals of Oncology · 2018 · 160 citations · Full text

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois et al. · Annals of Oncology · 2012 · 124 citations · Full text

Urology, Genitourinary Cancer, Medicine +7

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

Martin Schüler, Ahmad Awada, Philipp Harter et al. · Breast Cancer Research and Treatment · 2012 · 85 citations · Full text